BioCanRx is committed to bringing forward made-in-Canada therapies. The pace of research worldwide is accelerating at an incredible pace. The goal of BioCanRx is to fund development in future clinical trials so we're able to capitalize on those new discoveries and new treatments.
The products we work with are entirely novel and really represent a chance for cancer patients in Canada to access the best that science has to offer them. These are patients who have run out of options, who have exhausted the standard of care and who are looking to clinical trials in order to, perhaps, survive the disease they are confronted with. In our previous funding portfolio, we funded CAR T programs and had patients access therapies that were previously unavailable in Canada. I'm happy to report that they are four years post treatment, and they are still alive and doing very well as a result of the work of our network. Anything that interferes with bridging this gap....
Yes, ultimately, the downstream impact will be on the number of clinical trials that are supporting made-in-Canada solutions.
